IM Cannabis Corp., a leading medical cannabis company operating in Israel and Germany, has successfully closed a private placement offering, generating approximately US$4.1 million in gross proceeds. The offering involved the issuance of 2,050,000 units at a price of C$2.7427 per unit. Pure Equity Ltd. acted as a consultant for this transaction. The funds raised are intended for general working capital, repayment of existing debt, and other corporate purposes. The company has committed to filing a resale registration statement to facilitate the resale of shares by investors, with efforts to make it effective as soon as possible.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.